pharmacie et médicaments – Accès au traitement préventif du VIH "Lenacapavir"

This written question concerns access to the preventive treatment for HIV known as 'Lenacapavir'. It seeks information on the availability and accessibility of this new medication within the French healthcare system. The question is directed towards the government, likely the Minister of Health, to understand the steps being taken to ensure patients can benefit from this important preventive treatment.